Enabling Technologies for Low Resource Molecular Diagnostics
低资源分子诊断的支持技术
基本信息
- 批准号:8044040
- 负责人:
- 金额:$ 20万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAmericanArbovirusesAreaBedside TestingsBiological AssayBlood specimenBody FluidsCaringCessation of lifeClinicalCollaborationsCommunitiesComplexCulicidaeDNADengueDengue VirusDetectionDeveloping CountriesDevelopmentDevicesDiagnosisDiagnosticDisadvantagedDiseaseEconomicsEncephalitisFamilyFlaviviridaeFlavivirusGenderGenetic VariationGeographic LocationsGoalsHealthHealth Services AccessibilityHealth behaviorHourHumanIndividualInfectionInfectious AgentInsectaJapanese EncephalitisJapanese Encephalitis VirusesJapanese encephalitis virusLateralLifeMediatingMethodsMinority GroupsMolecularNatureNucleic AcidsPhasePreparationProcessQuality of CareRaceResearchResourcesRuralSamplingScientistSigns and SymptomsSmall Business Innovation Research GrantSpecificitySpecimenSystemTechniquesTechnologyTestingTicksTrainingUnited StatesVeterinary MedicineViral Hemorrhagic FeversVirusVisualWest Nile virusbasecostglobal healthinstrumentationinterestpoint of careprogramspublic health relevanceresponsesocial health determinantssocioeconomicstransmission process
项目摘要
DESCRIPTION (provided by applicant): The goal of this project is to integrate an isothermal amplification system with lateral flow detection to produce a simple, sensitive, low cost, all-in-one detection device for flaviviruse that is easily performed and interpreted in a point of care setting and is amenable to use in poorly served communities. The viruses of the family Flaviviridae, e.g. dengue, West Nile, and Japanese Encephalitis, are insect-borne viruses important to both human and veterinary medicine. According to WHO, dengue virus alone affected 1.2 million globally, resulting in 3442 deaths in 1998. These diseases are transmitted by mosquito and ticks and usually are maintained in a transmission cycle in nature. They are widely distributed throughout the world, although a specific flavivirus may be geographically restricted. They produce a broad spectrum of clinical responses in humans ranging from asymptomatic infection to fulminant encephalitis or haemorrhagic fever. Nearly 60 flaviviruses are known to exist, although but many are yet to be shown to cause disease in humans. They present with overlapping clinical signs and symptoms in similar geographic areas. The diagnosis of these infections is currently slow, expensive, and labor intensive and a delay in diagnoses often leads to serious sequelae and sometimes death. Thus, we propose to develop a comprehensive assay specific for several flaviviruses, with initial focus on dengue virus and West Nile virus. These tests are based on isothermal nucleic acid amplification technologies. We will compare the established technology, Loop-mediated AMPlification (LAMP), to our newly developed method SPIDR, which in early studies appears to be easier to implement and affords greater specificity. Both SPIDR and LAMP are isothermal techniques, precluding the need for thermocyclers and can produce results in less than 30 minutes. The amplification products will be processed in an integrated system using lateral flow technology, allowing sensitive, rapid, unambiguous detection with the potential for multiplexing. Once a test is developed, it will be very simple to perform and does not require DNA isolation for sample preparation (as compared to PCR). Such simplified detection facilitates interpretation by less skilled operators. When developed, the device will not require instrumentation or trained scientists to operate and is especially suitable to resource poor settings. The project is proposed by the PI in collaboration with several accomplished scientists across a broad field of synergistic research interests. The proposed research will address a fundamental, program-relevant need for a point of care test useful in developing country settings as well as for rural and socioeconomically disadvantaged Americans.
PUBLIC HEALTH RELEVANCE: The goal of this project is to fully integrate a simple, low cost, all-in-one amplification and detection device for flavivirus testing that is easily performed and interpreted in a point of care manner in resource poor settings. The device will not require instrumentation or
trained scientists to operate. The development of a reliable, sensitive and specific "point of care" test for flaviviruses in blood samples and other body fluids would be a major breakthrough for many low resource settings.
描述(由申请人提供):本项目的目标是将等温扩增系统与侧流检测相结合,以产生一种简单、灵敏、低成本、一体化的黄嘌呤检测装置,该装置易于在护理点环境中进行和解释,并且适合在服务较差的社区使用。黄病毒科的病毒,例如登革热、西尼罗河和日本脑炎,是对人类和兽医学都很重要的虫媒病毒。根据世界卫生组织的统计,1998年,仅登革热病毒就影响了全球120万人,导致3442人死亡。这些疾病由蚊子和蜱传播,通常在自然界中保持传播周期。它们广泛分布于世界各地,尽管特定的黄病毒可能受到地理限制。它们在人类中产生广泛的临床反应,从无症状感染到暴发性脑炎或出血热。已知存在近60种黄病毒,尽管其中许多尚未被证明会引起人类疾病。他们在相似的地理区域表现出重叠的临床体征和症状。这些感染的诊断目前是缓慢的,昂贵的,劳动密集型和诊断的延误往往会导致严重的后遗症,有时甚至死亡。因此,我们建议开发一种全面的检测特异性的几种黄病毒,最初的重点是登革热病毒和西尼罗河病毒。这些测试基于等温核酸扩增技术。我们将比较已建立的技术,环介导的AMP化(LAMP),我们新开发的方法SPIDR,在早期研究中似乎更容易实施,并提供更大的特异性。SPIDR和LAMP都是等温技术,不需要热循环仪,并且可以在不到30分钟内产生结果。扩增产物将在使用侧流技术的集成系统中进行处理,从而实现灵敏、快速、明确的检测,并具有多路复用的潜力。一旦开发了测试,它将非常容易执行,并且不需要DNA分离用于样品制备(与PCR相比)。这种简化的检测便于不太熟练的操作者进行解释。当开发出来时,该设备将不需要仪器或训练有素的科学家来操作,特别适合资源贫乏的环境。该项目是由PI与几位有成就的科学家在广泛的协同研究领域合作提出的。拟议的研究将解决一个基本的,与计划相关的需要,在发展中国家的设置以及农村和社会经济上处于不利地位的美国人有用的护理点测试。
公共卫生相关性:该项目的目标是完全集成一个简单,低成本,多合一的扩增和检测设备,用于黄病毒检测,易于在资源匮乏的环境中以护理点的方式进行和解释。该器械不需要手术工具,
训练科学家来操作。开发一种可靠、敏感和特异的“即时”检测血液样本和其他体液中的黄病毒的方法,将是许多资源匮乏环境的一项重大突破。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID Alan MEAD其他文献
DAVID Alan MEAD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID Alan MEAD', 18)}}的其他基金
High Fidelity Linear MicroVector to Clone Complex, Problematic, and Large DNAs
用于克隆复杂、有问题和大型 DNA 的高保真线性微载体
- 批准号:
9346284 - 财政年份:2017
- 资助金额:
$ 20万 - 项目类别:
Expression Enhanced Natural Product Pathways Using Advanced Metagenomic Tools
使用先进的宏基因组工具表达增强的天然产物途径
- 批准号:
8903016 - 财政年份:2015
- 资助金额:
$ 20万 - 项目类别:
Analytical Metagenomics Paradigm for Structure Based Screening
基于结构的筛选的分析宏基因组学范式
- 批准号:
8310684 - 财政年份:2012
- 资助金额:
$ 20万 - 项目类别:
Enabling Technologies for Low Resource Molecular Diagnostics
低资源分子诊断的支持技术
- 批准号:
7779226 - 财政年份:2010
- 资助金额:
$ 20万 - 项目类别:
NOVEL SOLUBILITY-ENHANCING PROTEIN EXPRESSION TECHNOLOGY
新型增强溶解度的蛋白质表达技术
- 批准号:
8501542 - 财政年份:2009
- 资助金额:
$ 20万 - 项目类别:
NOVEL SOLUBILITY-ENHANCING PROTEIN EXPRESSION TECHNOLOGY
新型增强溶解度的蛋白质表达技术
- 批准号:
8250969 - 财政年份:2009
- 资助金额:
$ 20万 - 项目类别:
Massively Parallel Single Cell Genomics of the Human Microbiome
人类微生物组的大规模并行单细胞基因组学
- 批准号:
7611525 - 财政年份:2008
- 资助金额:
$ 20万 - 项目类别:
HIGH THROUGHPUT CLONING OVEREXPRESSION AND PURIFICATION OF ACTIVE MEMBRANE PROT
活性膜保护的高通量克隆过表达和纯化
- 批准号:
7325336 - 财政年份:2007
- 资助金额:
$ 20万 - 项目类别:
Ex Cyto DNA Sequencing from Single Bacterial Colonies
单菌落的前细胞 DNA 测序
- 批准号:
7870519 - 财政年份:2006
- 资助金额:
$ 20万 - 项目类别:
Ex Cyto DNA Sequencing from Single Bacterial Colonies
单菌落的前细胞 DNA 测序
- 批准号:
7156326 - 财政年份:2006
- 资助金额:
$ 20万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Early-Career Scientists